Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
QAX028
DRUG
2 trials
Sponsors
Novartis
, Novartis Pharmaceuticals
Conditions
COPD
Chronic Obstructive Pulmonary Disease
Phase 1
Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.
Completed
NCT00568503
Novartis
COPD
Start: 2007-10-31
End: 2008-02-29
Updated: 2011-04-28
Phase 2
Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Completed
NCT01068613
Novartis Pharmaceuticals
Chronic Obstructive Pulmonary Disease
Start: 2010-01-31
End: 2010-08-31
Updated: 2020-12-19